Zyprexa Intramuscular, Olanzapine for Injection, 10 MG per Single Use Vial, Rx only, Marketed by: Lilly USA, LLC, Indianapolis, IN 46285, NDC# 0002-7597-01
Published August 18, 2021 · Recall initiated: June 29, 2021
Summary
FDA records drug Class II recall D-0720-2021, published August 18, 2021 and initiated June 29, 2021. Recalling firm: Eli Lilly & Company; Status: Terminated; Reported quantity: 36,540 vials; Lot: Lot # 197. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
cGMP deviations: Atypical appearance, decrease in size and change in color of the lyophilized cake of drug product.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Eli Lilly & Company
- Distributor
- OH, MS, IN
- Lot
- Lot # 197
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDASterile Diluent, HUMALOG U-100 (insulin lispro injection), HUMULIN R U-100 REGULAR (insulin human injection),April 24, 2024
- FDAGlucagon Emergency Kit for Low Blood Sugar, Glucagon for Injection, 1 mg per vial; Diluent for Glucagon, 1 mLOctober 20, 2021
- FDASulfamethoxazole and Trimethoprim Tablets, USP, 800mg/160mg Double Strength, 500 Tablets, Rx Only, DistributedAugust 18, 2021
- FDANystatin Oral Suspension, USP 100,000 units per mL, Cherry/Peppermint Flavor, Rx ONLY, packaged in a) 16 fl ozAugust 18, 2021
- FDAC-PROGESTERONE OIL 100 MG/ML, 10 mL vials, Compound, People's Custom Rx, Compounded, Rx only, People's CustomAugust 18, 2021
- FDAEthosuximide Oral Solution USP 250 mg/5 mL, 16 fl oz (473 mL), Rx ONLY, Pharmaceutical Associates, Inc.August 18, 2021
Questions about this recall
Was Zyprexa Intramuscular, Olanzapine for Injection, 10 MG per Single Use Vial, Rx only, Marketed by: Lilly USA, LLC, Indianapolis, IN 46285, NDC# 0002-7597-01 recalled?
Yes. FDA published recall D-0720-2021 on August 18, 2021. Reported hazard: cGMP deviations: Atypical appearance, decrease in size and change in color of the lyophilized cake of drug product.
What should I do if I have this product?
Voluntary: Firm initiated · Letter